In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From GC Pharma

Loss And Gain: Trade War Halves China Biotech VC Funding To US, But Asian Countries May Benefit

Chinese venture funding to the US biotech sector has fallen by nearly 60% in the latest sign of cooling in the previously booming bilateral life sciences investment sector.

China Financing

GC Pharma Hones R&D Focus, Tweaks US Immunoglobulin Strategy

Leading South Korean pharma firm GC Pharma realigns R&D priorities and resources and changes US strategy amid delayed approval of its immunoglobulin product.

South Korea Research & Development

Spotlight on Q1 Pharma M&A Merry-Go-Round

Q1 2019 saw a jump in merger and acquisition activity. Informa’s Biomedtracker has cast an analytical eye on three of the major deals, namely buys by Roche, Lilly and BMS.

M & A Market Intelligence

Invossa Fallout: Call For Review Of All Korea-Approved Cell Therapies

Although the big decision has been made for Invossa in Korea, things have not settled down and there have been calls for re-examination of all approved cell therapies, the recall of R&D grants provided to Kolon and expansion of a probe into the company’s leadership and government officials.

South Korea Gene Therapy
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Infectious & Viral Diseases
  • Inflammation
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Green Cross Corp.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • GC Pharma
  • Senior Management
  • Soon-Tae Cho, Pres.
  • Contact Info
  • GC Pharma
    Phone: (82) 31 260 9300
    107, Ihyeon-ro 30 beon-gil, Giheung-gu
    Yongin-Si
    Gyeonggi-Do, 449-770
    South Korea
Advertisement
Advertisement
UsernamePublicRestriction

Register